May 24 (Reuters) - Indian generic drugmaker Emcure Pharmaceuticals (EMCU.NS), opens new tab and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their ...

Colleen McClain, Olivia Sidoti and Monica Anderson contributed to this chapter. For many Americans, life in the early days of COVID-19 was lived on screens. Schools pivoted to virtual learning and ...

After demand for its COVID-19 shots plummeted, its new treatment for melanoma has reversed the Mass. company’s fortunes.

COVID-19 vaccine technology adapted to develop first mRNA defense against antibiotic-resistant bacteria by Tel-Aviv University edited by Gaby Clark, reviewed by Andrew Zinin Editors' notes The GIST ...

A business model born out of the disruptions of the Covid-19 pandemic has found its way into the classrooms of the Indian ...

Moderna's shares soared during the Covid vaccine boom before crashing as demand faded. A cancer breakthrough has now triggered the company's biggest-ever one-day gain, with the stock jumping 177%. Now ...

With the broad impact tariffs pose on society, it’s easy to find parallels to Covid-19. A sudden crisis dramatically upends operations, ebbs and flows, and lasts an unknown period. When Covid hit, ...

With their very existence at stake, many businesses are wondering what’s taking govt so long to provide a bailout. The coronavirus outbreak may negatively impact global growth by 30 basis points or ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...